The SUPPRESS-AF randomised trial showed no significant overall reduction in 1-year atrial tachyarrhythmia recurrence with additional left atrial low-voltage-area (LVA) ablation versus pulmonary vein isolation (PVI) alone in persistent atrial fibrillation (AF) with LVAs, underscoring the need to understand outcome...
N. Tanaka, M. Okada, M. Masuda et al.· European Heart Journal· 0 citations
In heart failure with preserved ejection fraction (HFpEF), left atrial (LA) enlargement is associated with adverse outcomes and pulmonary vascular disease.1 Although LA remodeling has traditionally been attributed to hypertension and chronic pressure overload secondary to left ventricular (LV) diastolic dysfuncti...
E. Hasegawa, T. Hayashi, Y. Yasumura et al.· European Heart Journal· 0 citations
LCA identified distinct AF phenotypes associated with prognoses that stratify prognosis and predict differential responses to catheter ablation strategies and may also provide insights into heterogeneity in response to ablation strategies.
Shun Sasaki, Y. Matsuoka, A. Sunaga et al.· European Heart Journal Open· 0 citations
In patients hospitalized for HFpEF with persistent AF, LAP classification was associated with HF hospitalization, implying clinical relevance of the 2025 algorithm-based approach in this challenging population.
K. Iwakura, S. Hoshida, Nobuaki Tanaka et al.· Journal of the American Soci...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.